Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 7;11(9):2480.
doi: 10.3390/biomedicines11092480.

Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?

Affiliations
Review

Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?

Alexandru Cosmin Pantazi et al. Biomedicines. .

Abstract

The gut microbiota (GM) plays a vital role in human health, with increasing evidence linking its imbalance to chronic kidney disease and end-stage kidney disease. Although the exact methods underlying kidney-GM crosstalk are not fully understood, interventions targeting GM were made and lay in three aspects: diagnostic, predictive, and therapeutic interventions. While these interventions show promising results in reducing uremic toxins and inflammation, challenges remain in the form of patient-specific GM variability, potential side effects, and safety concerns. Our understanding of GMs role in kidney disease is still evolving, necessitating further research to elucidate the causal relationship and mechanistic interactions. Personalized interventions focusing on specific GM signatures could enhance patient outcomes. However, comprehensive clinical trials are needed to validate these approaches' safety, efficacy, and feasibility.

Keywords: dysbiosis; gut microbiota; kidney disease; probiotic; uremic toxin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Causes of altered gut microbiota in patients with chronic kidney disease and end-stage kidney disease.
Figure 2
Figure 2
The clinical insight of GM in cases with CKD and ESKD.
Figure 3
Figure 3
Methods by which GM balance is restored in CKD and ESKD.

Similar articles

Cited by

References

    1. Gebrayel P., Nicco C., Al Khodor S., Bilinski J., Caselli E., Comelli E.M., Egert M., Giaroni C., Karpinski T.M., Loniewski I., et al. Microbiota Medicine: Towards Clinical Revolution. J. Transl. Med. 2022;20:111. doi: 10.1186/s12967-022-03296-9. - DOI - PMC - PubMed
    1. Pantazi A.C., Mihai C.M., Balasa A.L., Chisnoiu T., Lupu A., Frecus C.E., Mihai L., Ungureanu A., Kassim M.A.K., Andrusca A., et al. Relationship between Gut Microbiota and Allergies in Children: A Literature Review. Nutrients. 2023;15:2529. doi: 10.3390/nu15112529. - DOI - PMC - PubMed
    1. Nori W., Akram N.N., Mueen Al-kaabi M. Probiotics in Women and Pediatrics Health; A Narrative Review. Al-Anbar Med. J. 2023;19:10–16. doi: 10.33091/amj.2023.138442.1021. - DOI
    1. Lupu V.V., Adam Raileanu A., Mihai C.M., Morariu I.D., Lupu A., Starcea I.M., Frasinariu O.E., Mocanu A., Dragan F., Fotea S. The Implication of the Gut Microbiome in Heart Failure. Cells. 2023;12:1158. doi: 10.3390/cells12081158. - DOI - PMC - PubMed
    1. Pantazi A.C., Balasa A.L., Mihai C.M., Chisnoiu T., Lupu V.V., Kassim M.A.K., Mihai L., Frecus C.E., Chirila S.I., Lupu A., et al. Development of Gut Microbiota in the First 1000 Days after Birth and Potential Interventions. Nutrients. 2023;15:3647. doi: 10.3390/nu15163647. - DOI - PMC - PubMed

LinkOut - more resources